The operating story can stay strong while the stock outcome stays merely good. Amprius already trades as a scarcity asset, so most of the next five years likely come from revenue scaling into repeat defense, aerospace and light-mobility programs, while the
valuation multiple compresses from today’s very rich level. If the company proves outsourced scale, compliant supply and premium margins, the shares can still compound, but probably not in line with the raw revenue growth.